Kinetics of the Sublingual Microcirculation During Fluid Bolus
1 other identifier
observational
25
1 country
1
Brief Summary
Fluid therapy is one of the cornerstones of the treatment of organ failure. The investigators assume that fluid bolus will increase the delivery of oxygen to the cells and resolve the shock. The purpose of this study is to asses kinetics of the sublingual microcirculation in one place during a fluid bolus. It is expected that fluid therapy after normalization of the red blood cell flow velocity in the microcirculation will result in a decrease in capillary density through the formation of edema in the tissues. This can be considered to be the tipping of potentially beneficial to deleterious effects of fluid therapy. After cardiac surgery patient will be transferred to the ICU for further stabilisation. Within specific indications the patient will receive a fluid bolus, these indications are hypotension, hyperlactataemia, tachycardia or decreased urine production. The fluid bolus will be 250 ml crystalloids in 15 minutes. The investigators will observe the sublingual microcirculation during this fluid bolus. To asses the red blood cell velocity and capillary vessel density on one spot during this fluid bolus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 8, 2016
CompletedFirst Posted
Study publicly available on registry
February 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2018
CompletedMarch 27, 2018
March 1, 2017
2.3 years
January 8, 2016
March 26, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Red blood cell velocity
Measuring red blood cell velocity by using the microcirculatory blood flow index by eye-balling, (0: no flow; 1: stop-and-go; 2: sluggish; 3: normal flow)
before start fluid bolus, 5 min, 10 min, 15 min, 20 min after the start of the fluid bolus
Secondary Outcomes (1)
Change in Capillary vessel density
before start fluid bolus, 5 min, 10 min, 15 min, 20 min after the start of the fluid bolus
Study Arms (1)
Post cardiac surgery
Patients after cardiac surgery with signs of decreased organ perfusion and the need of fluid therapy.
Interventions
The normal treatment of a post-cardiac surgery patient is fluid bolus by indication. This indications are hypotension, hyperlactataemia, tachycardia or decreased urine production. This fluid bolus is 250 ml crystalloids in 15 minutes. When this fluid bolus will be given, the investigators will observe the sublingual microcirculation and measure the red blood cell velocity and total vessel density on one spot for 20 minutes.
Eligibility Criteria
Postoperative cardiac surgery patients
You may qualify if:
- \> 18 years old
- post-cardiac surgery and need for fluid therapy
You may not qualify if:
- recent maxillofacial surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical Centre Leeuwarden
Leeuwarden, Provincie Friesland, 8934 AD, Netherlands
Related Publications (5)
Pranskunas A, Koopmans M, Koetsier PM, Pilvinis V, Boerma EC. Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med. 2013 Apr;39(4):612-9. doi: 10.1007/s00134-012-2793-8. Epub 2012 Dec 20.
PMID: 23263029BACKGROUNDVeenstra G, Ince C, Boerma EC. Direct markers of organ perfusion to guide fluid therapy: when to start, when to stop. Best Pract Res Clin Anaesthesiol. 2014 Sep;28(3):217-26. doi: 10.1016/j.bpa.2014.06.002. Epub 2014 Jul 15.
PMID: 25208957BACKGROUNDvan Genderen ME, Klijn E, Lima A, de Jonge J, Sleeswijk Visser S, Voorbeijtel J, Bakker J, van Bommel J. Microvascular perfusion as a target for fluid resuscitation in experimental circulatory shock. Crit Care Med. 2014 Feb;42(2):e96-e105. doi: 10.1097/CCM.0b013e3182a63fbf.
PMID: 24158169BACKGROUNDXu J, Ma L, Sun S, Lu X, Wu X, Li Z, Tang W. Fluid resuscitation guided by sublingual partial pressure of carbon dioxide during hemorrhagic shock in a porcine model. Shock. 2013 Apr;39(4):361-5. doi: 10.1097/SHK.0b013e31828936aa.
PMID: 23364438BACKGROUNDInce C. The rationale for microcirculatory guided fluid therapy. Curr Opin Crit Care. 2014 Jun;20(3):301-8. doi: 10.1097/MCC.0000000000000091.
PMID: 24758985BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
E.C. Boerma, MD-PhD
Frisius Medisch Centrum
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 8, 2016
First Posted
February 5, 2016
Study Start
November 1, 2015
Primary Completion
February 15, 2018
Study Completion
February 15, 2018
Last Updated
March 27, 2018
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will not share